Improving Global Patient Access to Novel Radiopharmaceuticals
Who We Are
PharmaLogic is dedicated to advancing patient access to novel radiopharmaceuticals. Through robust infrastructure, deep technical expertise, and disciplined operational rigor, we enable pharmaceutical companies to efficiently advance products from clinical development to commercialization under the highest quality standards.
Explore Our Offerings
CDMO Services
We take the lead in advancing global patient access to diagnostic and therapeutic radiopharmaceuticals, delivering sponsors a unique suite of CMC and technical capabilities to support drug development from clinical development through commercial launch.
CMO Diagnostics
CMO Therapeutics
Supply Chain & Radiopharmacy
People
Our people make innovation possible. Guided by experienced leadership and united by purpose, we’re building a pipeline of talent to shape the future of radiopharmaceuticals.
In the Press
December 16, 2025
PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics’ Phase 1/2 Study of a Novel FAP-Targeted Radiopharmaceutical in Late-Stage Aggressive Sarcomas
ReadJune 2, 2025
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
ReadCareers
Our people combine an entrepreneurial mindset with disciplined execution to shape the future of radiopharmaceuticals.
Get in Touch
Have a question? Our team is ready to help you find the right solutions for your clinical and operational needs.